 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
3 News |  |
- |||| lidocaine bioadhesive gel, 10% (COL-1077) / Catalent
Trial completion, Biopsy: COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy (clinicaltrials.gov) - Jul 13, 2016
P2, N=187, Completed, Sponsor: Juniper Pharmaceuticals, Inc.
Recruiting --> Completed
- ||| lidocaine bioadhesive gel, 10% (COL-1077) / Catalent
Enrollment change, Trial primary completion date, Biopsy: COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy (clinicaltrials.gov) - May 13, 2016
P2, N=185, Recruiting, Sponsor: Juniper Pharmaceuticals, Inc.
Recruiting --> Completed N=150 --> 185 | Trial primary completion date: Feb 2016 --> Jun 2016
- | lidocaine bioadhesive gel, 10% (COL-1077) / Catalent
New P2 trial, Biopsy: COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy (clinicaltrials.gov) - Jun 6, 2015
P2, N=150, Recruiting, Sponsor: Juniper Pharmaceuticals, Inc.